Evotec (NASDAQ:EVO) Shares Gap Up to $4.57

Evotec SE (NASDAQ:EVO)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $4.57, but opened at $4.70. Evotec shares last traded at $4.67, with a volume of 13,041 shares traded.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft raised shares of Evotec from a “hold” rating to a “buy” rating in a research report on Friday, April 12th. HC Wainwright reaffirmed a “buy” rating and issued a $11.00 price objective on shares of Evotec in a research report on Thursday, May 23rd.

Evotec Stock Up 5.0 %

The stock’s 50-day moving average price is $5.02 and its two-hundred day moving average price is $7.18. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.79 and a current ratio of 1.86.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Mubadala Investment Co PJSC bought a new position in shares of Evotec during the 4th quarter valued at approximately $53,931,000. Optiver Holding B.V. boosted its holdings in Evotec by 643.1% in the 4th quarter. Optiver Holding B.V. now owns 80,810 shares of the company’s stock worth $945,000 after buying an additional 69,936 shares during the period. Cetera Advisors LLC bought a new position in Evotec in the 1st quarter worth approximately $188,000. Finally, Quadrant Capital Group LLC bought a new position in Evotec in the 4th quarter worth approximately $25,000. 5.81% of the stock is owned by institutional investors.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.